Omega Fund Management, LLC

Omega Fund Management, LLC reported 10 holdings worth US$125M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Omega Fund Management, LLC reported 10 holdings worth US$125M as of Sep 30, 2026. Largest: Nuvation Bio Inc., Bicara Therapeutics Inc. and Beta Bionics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
10
Value as reported
US$125M

The filing in full

CompanySharesValue as reported% of portfolio
Nuvation Bio Inc.7.15MUS$40M32.0%
Bicara Therapeutics Inc.1.76MUS$32.8M26.2%
Beta Bionics, Inc.962KUS$18.3M14.6%
BridgeBio Oncology Therapeutics, Inc.3.29MUS$13.5M10.8%
Kestra Medical Technologies, Ltd.362KUS$10.3M8.2%
Immunic, Inc.430KUS$4M3.2%
Sana Biotechnology, Inc.844KUS$2.46M2.0%
ImageneBio, Inc.455KUS$2.09M1.7%
enGene Holdings Inc.876KUS$1.75M1.4%
Odyssey Therapeutics, Inc.2,893US$64,2820.05%
Alumis Inc.0US$00.00%

Source

Download original · View original at SEC

Related